Empire Vision Centers | |
Route 30 North, Polar Plaza, Amsterdam, NY 12010-1610 | |
(518) 843-5353 | |
(518) 843-5562 |
Full Name | Empire Vision Centers |
---|---|
Type | Facility |
Speciality | Technician/technologist |
Location | Route 30 North, Amsterdam, New York |
Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477510444 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | (* (Not Available)) | Secondary |
156F00000X | Technician/technologist | (* (Not Available)) | Primary |
332H00000X | Eyewear Supplier | (* (Not Available)) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Empire Vision Centers 2921 Erie Blvd East, Syracuse, NY 13224-1430 Ph: (315) 446-3145 | Empire Vision Centers Route 30 North, Polar Plaza, Amsterdam, NY 12010-1610 Ph: (518) 843-5353 |
News Archive
Stereotaxis, Inc. announces the first successful cardiac ablation procedure with the Vdrive™ robotic navigation system as the company received CE Mark for this latest innovation.
Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today introduced Medidata Grants Manager 3.0, the newest version of its trial budgeting application in use today by many of the innovative clinical research sponsors in the life sciences industry. Now offered as a web-based solution, Grants Manager 3.0 enables users to build clinical trial grant budgets and benchmark them against Medidata's unique PICAS database of negotiated trial costs without the need to install software.
The nonmedical use of prescription opioids (POs) has become an area of increasing public health concern in the United States and rates of use are particularly high among young adults. In the past decade, an emerging "epidemic" of nonmedical PO use has been reported.
Duke University physicists have developed a way to produce sharp fluid jets with enough precision that they can inject material into a single, living cell. The technique promises a way to deliver drugs to cells one at a time, which is likely to be very valuable for research involving stem cells and other cellular-level studies. The research appears in the current issue of the APS journal Physical Review Letters.
› Verified 7 days ago